ES8200113A1 - Un procedimiento para la preparacion de derivados de cefalosporina. - Google Patents
Un procedimiento para la preparacion de derivados de cefalosporina.Info
- Publication number
- ES8200113A1 ES8200113A1 ES495137A ES495137A ES8200113A1 ES 8200113 A1 ES8200113 A1 ES 8200113A1 ES 495137 A ES495137 A ES 495137A ES 495137 A ES495137 A ES 495137A ES 8200113 A1 ES8200113 A1 ES 8200113A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- image
- hydrogen
- lower alkyl
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229930186147 Cephalosporin Natural products 0.000 title abstract 2
- -1 Cephalosporin compounds Chemical class 0.000 title abstract 2
- 229940124587 cephalosporin Drugs 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 7
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002071 phenylalkoxy group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11878879A JPS5643288A (en) | 1979-09-18 | 1979-09-18 | Cephalosporin derivative and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES495137A0 ES495137A0 (es) | 1981-10-16 |
| ES8200113A1 true ES8200113A1 (es) | 1981-10-16 |
Family
ID=14745096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES495137A Expired ES8200113A1 (es) | 1979-09-18 | 1980-09-17 | Un procedimiento para la preparacion de derivados de cefalosporina. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4393058A (show.php) |
| JP (1) | JPS5643288A (show.php) |
| AR (2) | AR227398A1 (show.php) |
| BE (1) | BE885265A (show.php) |
| CA (1) | CA1148142A (show.php) |
| DE (1) | DE3035259C2 (show.php) |
| ES (1) | ES8200113A1 (show.php) |
| FR (1) | FR2465739A1 (show.php) |
| GB (1) | GB2058769B (show.php) |
| IT (1) | IT1145390B (show.php) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4758557A (en) * | 1985-06-26 | 1988-07-19 | Meiji Seika Kaisha, Ltd. | Cephalosporin derivatives and bactericides containing the same |
| US5254571A (en) * | 1988-04-21 | 1993-10-19 | Smith Kline & French Laboratories Ltd. | Chemical compounds |
| DE19500760A1 (de) * | 1995-01-13 | 1996-07-18 | Basf Ag | Substituierte 2-Phenylpyridine |
| KR20030071311A (ko) * | 2002-02-28 | 2003-09-03 | 주식회사 엘지생명과학 | 신규 세팔로스포린 화합물 및 그의 제조방법 |
| JP4046708B2 (ja) * | 2004-06-04 | 2008-02-13 | 明治製菓株式会社 | ３−アルケニルセフェム化合物の製造方法 |
| US9650395B2 (en) | 2011-08-29 | 2017-05-16 | Ptc Therapeutics, Inc. | Antibacterial compounds and methods for use |
| JP2014525453A (ja) | 2011-08-29 | 2014-09-29 | ピーティーシー セラピューティクス， インコーポレイテッド | 抗菌化合物および使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS551273B2 (show.php) * | 1972-12-21 | 1980-01-12 | ||
| CA1074784A (en) * | 1974-09-06 | 1980-04-01 | Sumitomo Chemical Company | N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS |
| JPS5293790A (en) * | 1976-02-02 | 1977-08-06 | Sumitomo Chem Co Ltd | 7-(n-acylamino-alpha-arylacetamide) cephalosporins |
| US4302454A (en) * | 1976-03-03 | 1981-11-24 | Sumitomo Chemical Company, Limited | Cephalosporins |
| JPS5344585A (en) * | 1976-10-02 | 1978-04-21 | Meiji Seika Kaisha Ltd | Cephalosporin derivatives and their preparation |
| DE2658905A1 (de) * | 1976-12-24 | 1978-10-19 | Bayer Ag | Beta-lactam-antibiotica, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4101661A (en) * | 1977-06-03 | 1978-07-18 | Warner-Lambert | Novel antibacterial amide compounds and process means for producing the same |
| DE2924948A1 (de) * | 1979-06-21 | 1981-01-22 | Thomae Gmbh Dr K | Neue cephalosporine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
-
1979
- 1979-09-18 JP JP11878879A patent/JPS5643288A/ja active Pending
-
1980
- 1980-09-12 GB GB8029630A patent/GB2058769B/en not_active Expired
- 1980-09-12 CA CA000360265A patent/CA1148142A/en not_active Expired
- 1980-09-16 AR AR282537A patent/AR227398A1/es active
- 1980-09-17 IT IT49684/80A patent/IT1145390B/it active
- 1980-09-17 FR FR8020008A patent/FR2465739A1/fr active Granted
- 1980-09-17 ES ES495137A patent/ES8200113A1/es not_active Expired
- 1980-09-17 BE BE0/202127A patent/BE885265A/fr not_active IP Right Cessation
- 1980-09-18 US US06/188,417 patent/US4393058A/en not_active Expired - Lifetime
- 1980-09-18 DE DE3035259A patent/DE3035259C2/de not_active Expired
-
1981
- 1981-12-10 AR AR287751A patent/AR227452A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| ES495137A0 (es) | 1981-10-16 |
| AR227452A1 (es) | 1982-10-29 |
| JPS5643288A (en) | 1981-04-21 |
| BE885265A (fr) | 1981-01-16 |
| GB2058769A (en) | 1981-04-15 |
| AR227398A1 (es) | 1982-10-29 |
| IT8049684A0 (it) | 1980-09-17 |
| FR2465739A1 (fr) | 1981-03-27 |
| DE3035259A1 (de) | 1981-03-19 |
| CA1148142A (en) | 1983-06-14 |
| IT1145390B (it) | 1986-11-05 |
| FR2465739B1 (show.php) | 1983-06-17 |
| GB2058769B (en) | 1984-04-18 |
| US4393058A (en) | 1983-07-12 |
| DE3035259C2 (de) | 1986-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8306141A1 (es) | Un procedimiento para la produccion de un derivado de carbostirilo | |
| ES8407025A1 (es) | Un procedimiento para preparar derivados de nicotinamida. | |
| ES8704955A1 (es) | Un proceso para la produccion de un compuesto de cefalospo- rina | |
| ES8603242A1 (es) | Procedimiento para la obtencion de un derivado de nitrometi-leno | |
| DE3262698D1 (en) | Antifibrinolytically active compounds | |
| DE3061175D1 (en) | Glucosamine-peptide derivatives, their production and use | |
| ES8401961A1 (es) | Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas. | |
| ES486824A1 (es) | Procedimiento para la preparacion de nuevos derivados de 4- (naftilmetil) piperidinas | |
| ES466366A1 (es) | Un procedimiento para preparar derivados de metasulfonamido-benzamida. | |
| ES8103756A1 (es) | Un procedimiento para preparar compuestos de cefem | |
| ES444804A1 (es) | Procedimiento para la obtencion de derivados de tetrahidroi-soquinolina. | |
| ES8200113A1 (es) | Un procedimiento para la preparacion de derivados de cefalosporina. | |
| ES8700253A1 (es) | Procedimiento para preparar compuestos de 5-alquil-1-fenil- -2-piperazinoalquilpirazolin-3-ona | |
| ES8203867A1 (es) | Procedimiento para la obtencion de derivados de benzotiazol | |
| SE8304071L (sv) | Nya piperazinderivat | |
| ES8301882A1 (es) | Un procedimiento para la preparacion de un derivado de fene-tilamina | |
| ES8400743A1 (es) | "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona". | |
| ES8200648A2 (es) | Procedimiento de preparacion de compuestos opacificantes para radiografia y similares | |
| ES8406442A1 (es) | Un procedimiento para preparar compuestos de acido quinolilacetico | |
| ES2009925A6 (es) | Procedimiento para preparar nuevos tetrahidrofuranos y tetrahidrotiofenos. | |
| ES471267A1 (es) | Procedimiento para la preparacion de alquilo inferior 2-tri-(inferior) alquilsililacetileno-n-carbetoxiglicinatos y ami-no acidos derivados de ellos | |
| ES8101609A1 (es) | Un derivado de 7x-metoxicefalosporina | |
| ES8307233A1 (es) | Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico. | |
| SE8405338D0 (sv) | (1,3) oxazino (4,3-a) isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
| ATE29496T1 (de) | Tetrahydro-beta-carbolin-derivate und verfahren fuer ihre herstellung. |